Literature DB >> 22548402

Tomesa balneophototherapy in mild to severe psoriasis: a retrospective clinical trial in 174 patients.

Angelo Cattaneo1, Silvia Alberti Violetti, Simona Tavecchio, Elena Bruni, Carlo Carrera, Carlo Crosti.   

Abstract

Psoriasis is a chronic inflammatory skin disease with a high social and psychological impact on the quality of life of patients. Tomesa balneophototherapy is based on bathing in a magnesium-rich salt solution combined with exposure to narrowband ultraviolet B phototherapy. We conducted a retrospective clinical trial on 174 patients affected by mild to severe psoriasis undergoing Tomesa balneophototherapy. The basal course consisted of three to five sessions per week for a total of 30 sessions. Subsequently, patients could continue with a maintenance course of one session per week for a total of 30 sessions. We recorded a significant reduction of the mean Psoriasis Area and Severity Index (PASI) index with an achievement of at least PASI 75 in 52.1% of the 119 patients who completed the basal course and an improvement of the 'quality of life' of patients. The good efficacy obtained by this treatment, and the psychological impact on the quality of life of patients, demonstrated that Tomesa balneophototherapy could be a good option for the treatment of a chronic disease associated with psychological distress, like psoriasis.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 22548402     DOI: 10.1111/j.1600-0781.2012.00659.x

Source DB:  PubMed          Journal:  Photodermatol Photoimmunol Photomed        ISSN: 0905-4383            Impact factor:   3.135


  2 in total

1.  Indoor salt water baths followed by artificial ultraviolet B light for chronic plaque psoriasis.

Authors:  Frank Peinemann; Marco Harari; Sandra Peternel; Thalia Chan; David Chan; Alexander M Labeit; Thilo Gambichler
Journal:  Cochrane Database Syst Rev       Date:  2020-05-05

2.  Effect of Dead Sea Climatotherapy on Psoriasis; A Prospective Cohort Study.

Authors:  Thomas Emmanuel; Dorte Lybæk; Claus Johansen; Lars Iversen
Journal:  Front Med (Lausanne)       Date:  2020-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.